S&P 500   4,554.89 (+0.10%)
DOW   35,416.98 (+0.24%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
S&P 500   4,554.89 (+0.10%)
DOW   35,416.98 (+0.24%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
S&P 500   4,554.89 (+0.10%)
DOW   35,416.98 (+0.24%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
S&P 500   4,554.89 (+0.10%)
DOW   35,416.98 (+0.24%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

Applied Molecular Transport (AMTI) News Today

$0.18
+0.01 (+5.91%)
(As of 11/28/2023 ET)
Compare
Today's Range
$0.16
▼
$0.20
50-Day Range
$0.14
▼
$0.21
52-Week Range
$0.13
▼
$1.31
Volume
416,883 shs
Average Volume
484,332 shs
Market Capitalization
$7.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoApplied Molecular Transport Inc. (NASDAQ:AMTI) Director Tahir Ph.D. Mahmood Sells 286,320 Shares
americanbankingnews.com - November 28 at 5:28 AM
MarketBeat logoShawn Cross Sells 110,802 Shares of Applied Molecular Transport Inc. (NASDAQ:AMTI) Stock
americanbankingnews.com - November 27 at 6:14 AM
benzinga.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHS, AMTI, ESMT, CNSL
benzinga.com - November 22 at 12:25 PM
finance.yahoo.com logoApplied Molecular Transport Insider Ups Holding By 239% During Year
finance.yahoo.com - November 22 at 7:25 AM
finanznachrichten.de logoApplied Molecular Transport Inc.: Applied Molecular Transport Reports Third Quarter 2023 Financial Results
finanznachrichten.de - November 10 at 7:35 AM
msn.com logoApplied Molecular Transport GAAP EPS of -$0.17 beats by $0.33
msn.com - November 9 at 9:35 PM
finance.yahoo.com logoApplied Molecular Transport Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 9 at 4:34 PM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, ICPT, FNCB
markets.businessinsider.com - October 19 at 12:55 AM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMTI, CHS, FNCB, ICPT
markets.businessinsider.com - October 10 at 8:47 AM
barrons.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Applied Molecular Transport Inc. Buyout
barrons.com - September 22 at 1:40 PM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPLK, CYTH, AMTI, EBC
markets.businessinsider.com - September 21 at 10:40 PM
msn.com logoApplied Molecular to merge with Cyclo Therapeutics in all-stock deal
msn.com - September 21 at 12:39 PM
marketwatch.com logoCyclo Therapeutics to Buy Applied Molecular Transport in Stock Swap >CYTH AMTI
marketwatch.com - September 21 at 12:39 PM
marketbeat.com logo
marketbeat.com - September 21 at 8:03 AM
fool.com logoApplied Molecular Transport (NASDAQ: AMTI)
fool.com - September 8 at 12:49 AM
finanznachrichten.de logoApplied Molecular Transport Inc.: Applied Molecular Transport Reports Second Quarter 2023 Financial Results
finanznachrichten.de - August 18 at 7:05 PM
finance.yahoo.com logoApplied Molecular Transport Reports Second Quarter 2023 Financial Results
finance.yahoo.com - August 14 at 5:49 PM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Applied Molecular Transport Stock
finance.yahoo.com - May 16 at 3:37 PM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Applied Molecular Transport Stock \
finance.yahoo.com - May 16 at 3:37 PM
finanznachrichten.de logoApplied Molecular Transport Inc.: Applied Molecular Transport Reports First Quarter 2023 Financial Results
finanznachrichten.de - May 12 at 3:43 AM
finance.yahoo.com logoApplied Molecular Transport Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 5:42 PM
seekingalpha.com logoAMTI Applied Molecular Transport Inc.
seekingalpha.com - April 18 at 6:27 PM
bizjournals.com logoCEO exits Peninsula biotech Applied Molecular Transport amid job cuts, search for 'strategic alternatives'
bizjournals.com - March 28 at 8:55 PM
finanznachrichten.de logoApplied Molecular Transport Inc.: Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
finanznachrichten.de - March 28 at 3:55 PM
markets.businessinsider.com logo3 Analysts Have This to Say About Applied Molecular
markets.businessinsider.com - March 28 at 3:55 PM
markets.businessinsider.com logoApplied Molecular To Explore Strategic Alternatives
markets.businessinsider.com - March 27 at 5:57 PM
markets.businessinsider.com logoApplied Molecular To Explore Strategic Alternatives
markets.businessinsider.com - March 27 at 5:57 PM
finance.yahoo.com logoApplied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
finance.yahoo.com - March 27 at 5:57 PM
finance.yahoo.com logoApplied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic Alternatives
finance.yahoo.com - March 27 at 5:57 PM
marketbeat.com logo
marketbeat.com - March 27 at 4:04 PM
finance.yahoo.com logoWhat Makes Applied Molecular Transport Inc. (AMTI) a New Buy Stock
finance.yahoo.com - March 14 at 7:11 PM
seekingalpha.com logoApplied Molecular Transport GAAP EPS of -$0.58 beats by $0.01
seekingalpha.com - March 11 at 10:08 PM
finance.yahoo.com logoApplied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 9 at 5:49 PM
markets.businessinsider.com logoExpert Ratings for Applied Molecular
markets.businessinsider.com - March 6 at 6:17 PM
finance.yahoo.com logoApplied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 Congress
finance.yahoo.com - March 3 at 6:42 PM
finance.yahoo.com logoWe're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
finance.yahoo.com - February 24 at 6:55 PM
finance.yahoo.com logoApplied Molecular's Ulcerative Colitis Candidate Fails To Separate From Placebo In Untreated Patients
finance.yahoo.com - December 31 at 10:10 AM
msn.com logoWhat To Know About SVB Leerink's Downgrade of Applied Molecular
msn.com - December 27 at 2:30 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Applied Molecular Transport (AMTI)
markets.businessinsider.com - December 23 at 4:26 AM
finance.yahoo.com logoApplied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
finance.yahoo.com - December 22 at 8:13 PM
finance.yahoo.com logoAaron VanDevender Is The Independent Director of Applied Molecular Transport Inc. (NASDAQ:AMTI) And They Just Picked Up 239% More Shares
finance.yahoo.com - December 1 at 6:03 AM
finance.yahoo.com logoApplied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of Pouchitis
finance.yahoo.com - November 10 at 6:08 PM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Altimmune (ALT), Kura Oncology (KURA)
markets.businessinsider.com - November 8 at 8:23 AM
finance.yahoo.com logoApplied Molecular Transport to Present at Upcoming November Investor Conferences
finance.yahoo.com - November 8 at 8:23 AM
finance.yahoo.com logoApplied Molecular Transport Reports Third Quarter 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 8:03 PM
finance.yahoo.com logoApplied Molecular Transport Completes Enrollment of Phase 2 LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
finance.yahoo.com - September 20 at 5:11 PM
finance.yahoo.com logoHere's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
finance.yahoo.com - September 17 at 12:11 PM
morningstar.com logoApplied Molecular Transport Inc Ordinary Shares
morningstar.com - September 8 at 11:48 PM
nasdaq.com logoHere's Why Applied Molecular Transport (NASDAQ:AMTI) Must Use Its Cash Wisely
nasdaq.com - August 9 at 11:50 PM
finance.yahoo.com logoWhen Can We Expect A Profit From Applied Molecular Transport Inc. (NASDAQ:AMTI)?
finance.yahoo.com - August 7 at 1:01 PM
Get Applied Molecular Transport News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMTI and its competitors with MarketBeat's FREE daily newsletter.



AMTI Media Mentions By Week

AMTI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AMTI
News Sentiment
▼
-0.07

0.86
▲
Average
Medical
News Sentiment

AMTI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AMTI Articles
This Week
▼
9

0
▲
AMTI Articles
Average Week

Get Applied Molecular Transport News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMTI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AMTI) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -